Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04860596
Other study ID # TSMH IRB No 20-128-B
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 6, 2022
Est. completion date December 2023

Study information

Verified date August 2022
Source Antai Medical Care Corperation Antai Tian-Sheng Memorial Hospital/ Department of Nursing/National Ta
Contact Chih-Wen Chen
Phone 886-8329966
Email onlylandy567@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to explore the effect of the collaborative health management model on the functional status, quality of life and rehospitalization rate of patients with heart failure. This is a three-year project. The first phase (introduction phase): A systematic literature review and meta-analysis of collaborative care and heart failure patients will be conducted, and relevant research results will be evaluated for the clinical benefits of heart failure patients, and empirical knowledge will be proposed as The basic holistic conclusions are supported by the research literature on the establishment of a collaborative health management model for heart failure (CHMM). The second stage (construction period): based on the results of systematic literature review and meta-analysis, adopt the CHMM model, design intervention measures, and conduct pilot studies to determine the safety and feasibility of the research, and review future research improvements Wherever possible, develop more complete intervention measures. The third stage (operation period): Randomized controlled trials were adopted, with random sampling and double-blind research design. In the cardiology ward of a regional teaching hospital in the south, 120 patients with heart failure who met the admission criteria were selected, and 60 patients were selected as control group. The group received routine care in the hospital, and 60 of the experimental group received interventions in the collaborative health management model. Data collection includes variables such as physiological indices, functional status, self-care behavior, quality of life, re-admission rate, medical cost. Instruments tools include Minnesota Heart Failure Quality of Life Questionnaire, European Heart Failure Self-care Behavior Scale after the intervention 1 month, 2 months, and 3 months.The intervention effect will be statistically verified and analyzed by GEE. It is hoped that this care model will be applied to the clinical care of patients with heart failure, and will be verified by clinical benefits, reduce symptom troubles, improve quality of life, and reduce medical costs.


Description:

The purpose of this study is to explore the effect of the collaborative health management model on the functional status, self care, depression, quality of life and rehospitalization rate of patients with heart failure. This is a three-year project. The first phase (introduction phase): A systematic literature review and meta-analysis of collaborative care and heart failure patients will be conducted, and relevant research results will be evaluated for the clinical benefits of heart failure patients, and empirical knowledge will be proposed as The basic holistic conclusions are supported by the research literature on the establishment of a collaborative health management model for heart failure (CHMM). The second stage (construction period): based on the results of systematic literature review and meta-analysis, adopt the CHMM model, design intervention measures, and conduct pilot studies to determine the safety and feasibility of the research, and review future research improvements Wherever possible, develop more complete intervention measures. The third stage (operation period): Randomized controlled trials were adopted, with random sampling and double-blind research design. In the cardiology ward of a regional teaching hospital in the south, 120 patients with heart failure who met the admission criteria were selected, and 60 patients were selected as control group. The group received routine care in the hospital, and 60 of the experimental group received interventions in the collaborative health management model, including identifying high-risk patients and tracking them by electronic medical records, inter-disciplinary team members discussing patient issues, setting goals together, and passing cross-team members Jointly provide professional care, post-discharge outpatient and telephone follow-up case self-monitoring status, provide telephone consultation hotline, Data collection includes variables such as functional status, self-care behavior, depression, quality of life, re-admission rate. Instruments tools include European Heart Failure Self-care Behavior Scale, Beck Depression Inventory, Minnesota Heart Failure Quality of Life Questionnaire, after the intervention 1 month, 2 months, and 3 months.The intervention effect will be statistically verified and analyzed by GEE. It is hoped that this care model will be applied to the clinical care of patients with heart failure, and will be verified by clinical benefits, reduce symptom troubles, improve quality of life, and reduce medical costs.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 100 Years
Eligibility Inclusion Criteria: - ?Patients diagnosed as heart failure by specialists (NYHA ?-III); ?20 years of age or older; ?Patients with clear consciousness and no cognitive impairment and major diseases (such as cancer); ?Can communicate in Mandarin and Taiwanese; ? Those who can answer the questionnaire by themselves or with the assistance of a research assistant. Exclusion Criteria: - NIL

Study Design


Related Conditions & MeSH terms

  • Heart Failure
  • Heart Failure With Reduced Ejection Fraction (HFrEF)

Intervention

Behavioral:
collaborative health management model
nursing education program

Locations

Country Name City State
Taiwan Antai Medical Care Cooperation Antai Tian-Sheng Memorial Hospital Pingtung Donggang Township
Taiwan Research team Pingtung

Sponsors (1)

Lead Sponsor Collaborator
Antai Medical Care Corperation Antai Tian-Sheng Memorial Hospital/ Department of Nursing/National Ta

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary CHF functional status NYHAClass ?~? pre intervenation
Primary CHF functional status NYHAClass ?~? post intervention 1 months
Primary CHF functional status NYHAClass ?~? post intervention 2 months
Primary CHF functional status NYHAClass ?~? post intervention 3 months
Primary CHF quality of life Minnesota living with heart failure questionnaire, MLHFQ pre intervention
Primary CHF quality of life Minnesota living with heart failure questionnaire, MLHFQ post intervention 1 months
Primary CHF quality of life Minnesota living with heart failure questionnaire, MLHFQ post intervention 2 months
Primary CHF quality of life Minnesota living with heart failure questionnaire, MLHFQ post intervention 3 months
Primary CHF rehospitalization Re-admission rate pre intervention
Primary CHF rehospitalization Re-admission rate post intervention 1 months
Primary CHF rehospitalization Re-admission rate post intervention 2 months
Primary CHF rehospitalization Re-admission rate post intervention 3 months
Primary CHF Self care behaviour Heart Failure Self-Care Behaviour Sacle, EHFScBS pre intervention
Primary CHF Self care behaviour Heart Failure Self-Care Behaviour Sacle, EHFScBS post intervention 1 months
Primary CHF Self care behaviour Heart Failure Self-Care Behaviour Sacle, EHFScBS post intervention 2 months
Primary CHF Self care behaviour Heart Failure Self-Care Behaviour Sacle, EHFScBS post intervention 3 months
Primary CHF Depression Beck Depression Inventory(BDI) pre intervention
Primary CHF Depression Beck Depression Inventory(BDI) post intervention 1 months
Primary CHF Depression Beck Depression Inventory(BDI) post intervention 2 months
Primary CHF Depression Beck Depression Inventory(BDI) post intervention 3 months
See also
  Status Clinical Trial Phase
Completed NCT05328752 - Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF) Phase 1
Recruiting NCT05420012 - The Effect of Vericiguat on Peripheral Vascular Function, Patient Health Status and Inflammation Phase 4
Active, not recruiting NCT05136820 - Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study N/A
Not yet recruiting NCT04304560 - Value of SGLT2 Inhibitor (Dapagliflozin) as an Added Therapy in Diabetic Patients With Heart Failure With Reduced Ejection Fraction; Randomized Controlled Clinical Trial Phase 2
Completed NCT04180696 - Mid-Q Response Study N/A
Recruiting NCT04331769 - Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study N/A
Completed NCT03877237 - DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction Phase 3